SAMPLE REPORT · DEMONSTRATION DATA · NOT REAL PATIENTS

Chronic-care outcomes report

Sample Health Plan · Q3 2026

412 enrolled members · Programme month 6 · Reporting period 1 Jul – 30 Sep 2026

Hypertension 268 Diabetes 151 Dialysis 38

Conditions overlap: 45 members have both hypertension and diabetes. Baseline is each member's first 30 days on the programme.

Programme summary

Active monthly

81%

target over 75%

Retained at 6 months

84%

90% at 3 months

On-time refills

86%

baseline 58%

Avg refill gap

2.1 days

baseline 9.4 days

Alert to contact

5.2 hrs

median, 94% same day

Reviews attended

78%

baseline 61%

Hypertension

268 members · target below 140/90 mmHg

BP at target

61%

from 38%

Mean BP

138/86

from 152/94

Weekly readings logged

74%

Urgent readings escalated

17

all contacted within 4 hrs

Members with BP at target, by programme month
38%
44%
49%
54%
58%
61%
M1M2M3M4M5M6

Diabetes

151 members · 118 with a repeat HbA1c at month 6

HbA1c below 7%

44%

from 29%

Mean HbA1c

7.8%

from 8.6%

Glucose readings in range

58%

from 41% (4.4–7.2 mmol/L fasting)

Low-glucose alerts

11

all contacted within 24 hrs

HbA1c distribution, baseline vs month 6 (n = 118)

Baseline

29%
41%
30%

Month 6

44%
38%
18%
Below 7% (at goal) 7–9% Above 9% (high risk)

Dialysis

38 members · 1,368 scheduled sessions this quarter (3 per week)

Sessions captured

94%

1,284 of 1,368

Kt/V at target

79%

≥1.2 · mean 1.31

Missed sessions

3.2%

from 6.1%

High fluid gain (over 4%)

14%

of sessions, from 22%

Sessions captured and clinician-reviewed within 72 hrs, by month
Captured Reviewed within 72 hrs
M1 88 / 80M2 91 / 84M3 93 / 88M4 95 / 90M5 96 / 92M6 97 / 93

What this quarter shows

• BP control rose steadily each month, with the biggest gains among members whose family Circle funds refills.

• High-risk diabetes (HbA1c above 9%) fell from 30% to 18% of members with repeat tests.

• Nearly every outside dialysis session now reaches a clinician within three days.

How these figures are produced

Home readings from the TunzaCare app, clinic and lab results shared by partner hospitals, and refill records from partner pharmacies. Members consented to aggregated reporting. No individual is identifiable. Targets follow the treating clinicians' protocols.

WhatsApp us